MGV
MGV is a diversified life sciences company driving innovation across therapeutic discovery and development.
Our core operating units integrate advanced biotechnology, engineering, and computing to dramatically accelerate R&D efficiency. Our team includes recognized leaders from Sanofi, Abbvie, Harvard, MIT, Regeneron, Merck, and other leading institutions. We pursue breakthrough science across a wide range of therapeutic areas, including autoimmunity, nephrology, ophthalmology, oncology, infectious diseases, and others, leveraging both biologics and small molecules.
MGV operates through a flexible, partnership-driven model—including in- and out-licensing of our proprietary platforms and pipeline assets (preclinical and clinical), as well as strategic investments—to unlock value across the life sciences ecosystem.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}